How Big Pharma holds back in the war on cancer

Newer cancer drugs have in some cases shown dramatic life-extending results for patients. Yet cancer remains the second-most-common cause of death in the U.S. after heart disease, killing about 580,000 people a year. Research by Michelle Holmes, associate professor of medicine at Brigham and Women’s Hospital, is cited. Vikas Sukhatme, the Victor J. Aresty Professor of Medicine at Beth Israel Deaconess Medical Center, is also quoted.

Read full article